«Our research shows that targeting cannabinoid receptors in the periphery with pharmacological inhibitors that do not
reach the brain holds promise as a safe therapeutic approach for the treatment of overeating and diet - induced obesity,» said Nicholas V. DiPatrizio, an assistant professor of biomedical sciences in the School of Medicine, who led the research project.